Berolina innovative Research and Development Services Pharma AG (BiRDS Pharma AG), a company integrated into the network of the BDD/CCDRD Group, provides a broad range of services in the field of drug development to pharmaceutical/biotech companies and pursues own drug development projects based on IP generated within the Group.
Based on the expertise and know how of the Group as well as on proprietary process and technology platforms, the services offered by BIRDS Pharma AG include management of drug development projects in all phases from early stage to compilation of Dossier for submission as well as a variety of creative solutions for portfolio management and development of premium drugs. Additionally, BiRDS Pharma AG offers a broad range of consulting services to pharmaceutical and biotech companies, including drug development consulting and IT consulting.
For own drug development, BiRDS Pharma AG is focussing on the development of the most promising drug candidates form the groupīs project pipeline based on Atomic Substitution Technology (AST). Furthermore, as partner of BDD/CCDRD Group affiliates OSSOGEN Biopharm GmbH and DORO Development GmbH, BiRDS Pharma AG is also involved in the development of biologicals and improved generics. The projects are taken at fast track to a development stage that allows for partnering with the pharmaceutical industry. |
